Stephanie Krebs - Email & Phone Number

VP, Head of Business Development at Valo Health

Stephanie Krebs is based out of Greater Boston and works at Valo Health as VP, Head of Business Development.

Stephanie Krebs's Contact Information

Stephanie Krebs's Work email

s*****@valohe***.com

Valid

Latest update

October 12, 2025

Location

Greater Boston

Stephanie's current employer

Valo Health

Description

Valo is a new type of technology company, uniting human and machine intelligence aiming to accelerate the creation of life-changing cures.

Website

valohealth.com

HQ Location

Boston, MA, United States

Number of employees

51-200

Industry

Biotechnology Research

Latest update

April 30, 2024

Read about Valo Health

Frequent questions about Stephanie Krebs

What company is Stephanie Krebs working for?

Stephanie Krebs works for Valo Health.

What is Stephanie Krebs's function at Valo Health?

Stephanie Krebs is VP, Head of Business Development at Valo Health.

Where is Stephanie Krebs based?

Stephanie Krebs is based out of Greater Boston.

What is Stephanie Krebs's work email address?

Stephanie Krebs's professional email address is s*****@valohe***.com

Who are Stephanie Krebs's co-workers?

Stephanie Krebs's colleagues are David Berry, Dave Morris, Michael Graziano, Eric Stangeland, Kendyl Schaefer, Sean Kim, Jeffrey Prowda, Jonathan O'Connell, David Tester, Scott Webster, Kosta Haveles, Jennifer Burdman, Sarah Zenz, Guido Lanza, Nish Lathia, Moni Miyashita, John Griffin, Graeme Bell, Laurent Gautier, Philip Yin, Jonathan Grob, Konstantinos Kleitsas, Kimberly Kapner, Galen Day, James Bullis, Leon Furchtgott, Brett Blackman, Alexander Rajan, Jessen Yu, Steven Lesiak, Meghan Garcia, Ella Nkhoma, Winston Larson, Nathan Bays, Mike Devlin.

Stephanie's co-workers

David Berry

Founder and CEO

Dave Morris

President, Head of Therapeutics and Technology

Michael Graziano

Senior Vice President and Chief Scientific Officer

Eric Stangeland

Vice President, Head of Discovery Sciences

Kendyl Schaefer

VP, Portfolio and Program Management

Sean Kim

Vice President, Clinical Pharmacology, DMPK and Toxicology

Jeffrey Prowda

Senior Vice President and General Counsel

Jonathan O'Connell

Vice President, Early Discovery & Technology at Valo Health

David Tester

VP, Data Sciences & Machine Learning

Scott Webster

VP, Technical Program Management

Kosta Haveles

Vice President, Talent

Jennifer Burdman

VP, Chief Counsel - Technology & Therapeutics, Chief IP Officer, Deputy General Counsel

Sarah Zenz

Vice President Of Product Management

Guido Lanza

VP of Integrated Research

Nish Lathia

Executive Vice President, Chief Product Officer

Moni Miyashita

EVP and Chief Strategy Officer

John Griffin

Vice President, Molecular Design & Discove

Vice President, Head of Clinical Development

Jonathan Grob

Sr. Director - Head of Early Discovery Chemistry

Konstantinos Kleitsas

Director, Organizational Effectiveness

Kimberly Kapner

Head of Talent Acquisition

Galen Day

Senior Director, FP&A

James Bullis

Senior Principal Scientist, Head of Lab Informatics

Leon Furchtgott

Associate Director, Data Science

Brett Blackman

Chief Innovation Officer, Head of Corporate Business Development

Alexander Rajan

Director of Data Science

Jessen Yu

Senior Director

Steven Lesiak

Sr. Director, Finance & Operations

Meghan Garcia

Associate Director - Portfolio & Program Management

Ella Nkhoma

Senior Director, Data Science, Clinical Real World Evidence

Winston Larson

Executive Director, Corporate Strategy

Nathan Bays

Senior Director, Data and Assay Technologies

Mike Devlin

Lead Security Engineer

Browse & Connect

Browse companies

Our company index contains hundreds of thousands of businesses.

a b c d e f g h i j k l m n o p q r s t u v w x y z

Wiza does not guarantee or claim any of the information found on this public directory to be 100% accurate or up to date.Information found here is gathered from a variety of online and offline sources.If you wish to exclude your personal data from this public directory please fill out the optout form.